Company Filing History:
Years Active: 2017
Title: The Innovative Journey of Piotr Wałejko
Introduction
Piotr Wałejko, an accomplished inventor based in Białystok, Poland, has made noteworthy contributions to the field of vitamin synthesis. His work primarily focuses on the preparation of MK-7 type of vitamin K2, a vital compound for various biological functions.
Latest Patents
Wałejko holds a patent for the "Process for preparation of MK-7 type of vitamin K2." This innovative process is characterized by the attachment of a hexaprenyl chain of 'all-trans' configuration to a monoprenyl derivative of menadiol through a '1+6' synthetic strategy. The invention involves generating a-sulfonyl carbanion in situ from the protected monoprenyl menadiol, which then reacts with hexaprenyl halide through an alkylation reaction. The synthesis process ensures the effective coupling of two triprenyl units to form the hexaprenyl halide.
Career Highlights
Currently, Wałejko is employed at Nattopharma R & D Ltd., a company dedicated to innovative nutritional solutions. His expertise in synthetic strategies has been instrumental in the development of effective vitamin K2 formulations. His sole patent reflects his commitment to advancing nutritional science through innovative methodologies.
Collaborations
Throughout his career, Wałejko has collaborated with notable colleagues such as Krzysztof Krajewski and Andrzej Kutner. These partnerships have facilitated the sharing of insights and have contributed to successful research outcomes in the realm of vitamin synthesis.
Conclusion
Piotr Wałejko stands out in the field of innovation, with a significant focus on the synthesis of vital vitamins. His dedication to research and development at Nattopharma R & D Ltd. not only showcases his innovative spirit but also emphasizes the importance of collaborative efforts in the advancement of scientific knowledge.